World's Best Scientists 2026 revealed!
Nasser K. Altorki

Nasser K. Altorki

D-Index & Metrics

Medicine

D-Index
104
Citations
47375
World Ranking
6976
National Ranking
3670

Nasser K. Altorki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nasser K. Altorki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 615 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nasser K. Altorki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nasser K. Altorki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nasser K. Altorki is affiliated with Cornell University in the United States and has a significant body of work within the field of Medicine, focusing primarily on Pulmonary and Respiratory Medicine, Oncology, and Surgery, with additional contributions to Molecular Biology and Radiology, Nuclear Medicine and Imaging.

Their research extensively covers topics related to Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, as well as Esophageal Cancer Research and Treatment. Further areas of interest include Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics, and Gastric Cancer Management and Outcomes.

Frequent co-authors include:

  • Jeffrey L. Port
  • Olivier Elemento
  • Jonathan Villena-Vargas
  • Timothy E. McGraw
  • S. Harrison

Altorki's work is published predominantly in key venues such as:

  • Journal of Thoracic and Cardiovascular Surgery
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Thoracic Oncology
  • Cancer Research
  • Journal of Clinical Oncology

Notable recent publications include:

  • "Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer," 2023, New England Journal of Medicine
  • "Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial," 2021, The Lancet Oncology

Other papers associated with Altorki's co-authors reflect the broader research environment they are part of, including work published in The Lancet, Nature Medicine, and Annals of Oncology on topics such as adjuvant therapies and cancer monitoring.

Best Publications

  • VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Rosandra N. Kaplan;Rebecca D. Riba;Stergios Zacharoulis;Anna H. Bramley

  • Early Lung Cancer Action Project: overall design and findings from baseline screening

    Claudia I Henschke;Dorothy I McCauley;David F Yankelevitz;David P Naidich

  • Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

    Kari R. Fischer;Anna Durrans;Sharrell Lee;Jianting Sheng

  • TOX is a critical regulator of tumour-specific T cell differentiation

    Andrew C Scott;Andrew C Scott;Friederike Dündar;Paul Zumbo;Smita S Chandran

  • Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.

    Enriqueta Felip;Nasser Altorki;Caicun Zhou;Tibor Csőszi

  • The lung microenvironment: an important regulator of tumour growth and metastasis

    Nasser K. Altorki;Geoffrey J. Markowitz;Dingcheng Gao;Jeffrey L. Port

  • Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database

    Subroto Paul;Nasser K. Altorki;Shubin Sheng;Paul C. Lee

  • Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer.

    Andrew J Dannenberg;Nasser K Altorki;Jay O Boyle;Chau Dang

  • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Sacha Gnjatic;Djordje Atanackovic;Elke Jäger;Mitsutoshi Matsuo

  • Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

    Achim A. Jungbluth;Yao-Tseng Chen;Elisabeth Stockert;Klaus J. Busam

  • Early lung cancer action project: initial findings on repeat screenings.

    Claudia I. Henschke;David P. Naidich;David F. Yankelevitz;Georgeann McGuinness

  • The Number of Lymph Nodes Removed Predicts Survival in Esophageal Cancer: An International Study on the Impact of Extent of Surgical Resection

    Christian G Peyre;Jeffrey A Hagen;Steven R DeMeester;Nasser K Altorki

  • Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus

    Nasser Altorki;Michael Kent;Cathy Ferrara;Jeffrey Port

  • Inhibition of cyclooxygenase-2 gene expression by p53.

    Kotha Subbaramaiah;Nasser Altorki;Wen Jing Chung;Juan R. Mestre

  • Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

    Johan F. Vansteenkiste;Byoung Chul Cho;Tonu Vanakesa;Tommaso De Pas

  • MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival

    Ewy A. Mathé;Giang Huong Nguyen;Elise D. Bowman;Yiqiang Zhao;Yiqiang Zhao

  • Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial

    Karen Kelly;Nasser K. Altorki;Wilfried E.E. Eberhardt;Mary E.R. OBrien

  • Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    Ali O. Gure;Ramon Chua;Barbara Williamson;Mithat Gonen

  • TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

    Zhan Yao;Silvia Fenoglio;Ding Cheng Gao;Matthew Camiolo

  • Prediction of lung cancer using volatile biomarkers in breath.

    Michael Phillips;Nasser Altorki;John H.M. Austin;Robert B. Cameron

Frequent Co-Authors

Vivek Mittal
Vivek Mittal Cornell University
David F. Yankelevitz
David F. Yankelevitz Icahn School of Medicine at Mount Sinai
Andrew J. Dannenberg
Andrew J. Dannenberg Cornell University
Claudia I. Henschke
Claudia I. Henschke Cornell University
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Kotha Subbaramaiah
Kotha Subbaramaiah Cornell University
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Timothy E. McGraw
Timothy E. McGraw Cornell University
Paul J. Christos
Paul J. Christos Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens many doors to related online programs and career opportunities. For those interested in the business and organizational side of healthcare, a healthcare administration degree can prepare you for management roles in diverse medical settings. Many programs now offer flexible online learning options, ideal for those balancing work and study.

Registered nurses who aspire to advanced practice can accelerate their careers with rn to np bridge programs. These programs enable RNs to become nurse practitioners, often in less time than traditional routes.

Nutrition is another growing field within healthcare. An online nutrition degree prepares students for roles in dietetics, wellness coaching, and health education, while offering the convenience of remote study.

For aspiring healthcare leaders, choosing the right program is essential. Find out which online healthcare administration programs have cahme accreditation? to ensure your degree meets rigorous industry standards and boosts your career prospects.

Best Scientists Citing Nasser K. Altorki

Trending Scientists

Recently Published Articles